Cargando…
Rat N-ERC/Mesothelin as a Marker for In Vivo Screening of Drugs against Pancreas Cancer
Pancreatic ductal adenocarcinoma (PDA) is a highly lethal disease, which is usually diagnosed in an advanced stage. We have established transgenic rats carrying a mutated K-ras gene controlled by Cre/loxP activation. The animals develop PDA which is histopathologically similar to that in humans. Pre...
Autores principales: | Fukamachi, Katsumi, Iigo, Masaaki, Hagiwara, Yoshiaki, Shibata, Koji, Futakuchi, Mitsuru, Alexander, David B., Hino, Okio, Suzui, Masumi, Tsuda, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4210215/ https://www.ncbi.nlm.nih.gov/pubmed/25347530 http://dx.doi.org/10.1371/journal.pone.0111481 |
Ejemplares similares
-
Evaluation of a biomarker for the diagnosis of pancreas cancer using an
animal model
por: Fukamachi, Katsumi, et al.
Publicado: (2019) -
ERC/mesothelin is expressed in human gastric cancer tissues and cell lines
por: ITO, TOMOAKI, et al.
Publicado: (2014) -
Newly established ELISA for N-ERC/mesothelin improves diagnostic accuracy in patients with suspected pleural mesothelioma
por: Sato, Tadashi, et al.
Publicado: (2014) -
Possible reversibility between epithelioid and sarcomatoid types of mesothelioma is independent of ERC/mesothelin expression
por: Kojima, Masataka, et al.
Publicado: (2020) -
Bisecting-GlcNAc on Asn388 is characteristic to ERC/mesothelin expressed on epithelioid mesothelioma cells
por: Fujihira, Haruhiko, et al.
Publicado: (2021)